News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
192,059 Results
Type
Article (12920)
Company Profile (32)
Press Release (179107)
Multimedia
Podcasts (10)
Webinars (6)
Section
Business (53003)
Career Advice (604)
Deals (8219)
Drug Delivery (31)
Drug Development (28670)
Employer Resources (52)
FDA (6321)
Job Trends (5413)
News (98917)
Policy (11363)
Tag
2024 BioCapital Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Digital (2)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (3)
2024 Biotech Bay Standard (1)
2024 Biotech Beach Digital (1)
2024 Genetown Standard (1)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Standard (1)
2025 Lone Star Bio Digital (1)
2026 BioMidwest Elite (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (1)
Academia (1142)
Academic (1)
Accelerated approval (2)
Adcomms (12)
Allergies (35)
Alliances (15570)
ALS (35)
Alzheimer's disease (516)
Antibody-drug conjugate (ADC) (44)
Approvals (6351)
Artificial intelligence (89)
Autoimmune disease (6)
Automation (12)
Bankruptcy (60)
Best Places to Work (4353)
BIOSECURE Act (6)
Biosimilars (28)
Biotechnology (20)
Bladder cancer (35)
Brain cancer (13)
Breast cancer (100)
Cancer (921)
Cardiovascular disease (81)
Career advice (536)
Career pathing (17)
CAR-T (57)
Cell therapy (135)
Cervical cancer (12)
Clinical research (24350)
Collaboration (271)
Compensation (16)
Complete response letters (12)
COVID-19 (996)
CRISPR (12)
C-suite (39)
Cystic fibrosis (30)
Data (911)
Denatured (2)
Depression (13)
Diabetes (77)
Diagnostics (3910)
Digital health (5)
Diversity, equity & inclusion (9)
Drug discovery (50)
Drug pricing (24)
Drug shortages (4)
Duchenne muscular dystrophy (42)
Earnings (19445)
Editorial (6)
Employer branding (8)
Employer resources (44)
Events (20988)
Executive appointments (169)
FDA (6772)
Featured Employer (8)
Friedreich's ataxia (1)
Frontotemporal dementia (3)
Funding (206)
Gene editing (23)
Generative AI (5)
Gene therapy (113)
GLP-1 (271)
Government (1912)
Grass and pollen (3)
Guidances (20)
Healthcare (4809)
Huntington's disease (8)
IgA nephropathy (8)
Immunology and inflammation (37)
Indications (13)
Infectious disease (1061)
Inflammatory bowel disease (31)
Influenza (27)
Intellectual property (19)
Interviews (82)
IPO (3118)
IRA (5)
Job creations (1261)
Job search strategy (484)
Kidney cancer (5)
Labor market (18)
Layoffs (103)
Leadership (9)
Legal (1921)
Liver cancer (26)
Lung cancer (146)
Lymphoma (87)
Machine learning (4)
Management (13)
Manufacturing (111)
MASH (18)
Medical device (2835)
Medtech (2835)
Mergers & acquisitions (5241)
Metabolic disorders (199)
Multiple sclerosis (35)
NASH (6)
Neurodegenerative disease (32)
Neuropsychiatric disorders (6)
Neuroscience (727)
NextGen: Class of 2025 (1632)
Non-profit (1096)
Northern California (729)
Now hiring (21)
Obesity (103)
Opinion (87)
Ovarian cancer (32)
Pain (31)
Pancreatic cancer (28)
Parkinson's disease (65)
Partnered (9)
Patents (44)
Patient recruitment (44)
Peanut (23)
People (14065)
Pharmaceutical (12)
Pharmacy benefit managers (3)
Phase I (7302)
Phase II (10402)
Phase III (8772)
Pipeline (450)
Policy (24)
Postmarket research (1051)
Preclinical (1969)
Press Release (34)
Prostate cancer (50)
Psychedelics (11)
Radiopharmaceuticals (78)
Rare diseases (142)
Real estate (2817)
Recruiting (22)
Regulatory (8388)
Reports (18)
Research institute (1059)
Resumes & cover letters (60)
Rett syndrome (3)
RNA editing (2)
RSV (17)
Schizophrenia (27)
Series A (36)
Series B (16)
Service/supplier (2)
Sickle cell disease (17)
Southern California (610)
Special edition (5)
Spinal muscular atrophy (86)
Sponsored (11)
Startups (1053)
State (1)
Stomach cancer (10)
Supply chain (19)
Tariffs (6)
The Weekly (7)
United States (6635)
Vaccines (172)
Venture capitalists (9)
Weight loss (77)
Women's health (10)
Worklife (5)
Date
Today (48)
Last 7 days (198)
Last 30 days (745)
Last 365 days (10127)
2025 (2937)
2024 (10867)
2023 (12633)
2022 (16916)
2021 (17363)
2020 (16966)
2019 (12853)
2018 (9665)
2017 (9811)
2016 (9409)
2015 (10517)
2014 (7829)
2013 (6718)
2012 (7058)
2011 (7442)
2010 (6318)
Location
Africa (231)
Alabama (30)
Alaska (2)
Arizona (49)
Arkansas (5)
Asia (11587)
Australia (1918)
California (1621)
Canada (539)
China (135)
Colorado (76)
Connecticut (92)
Delaware (49)
Europe (26486)
Florida (186)
Georgia (47)
Idaho (15)
Illinois (134)
India (14)
Indiana (105)
Iowa (4)
Japan (76)
Kansas (28)
Kentucky (13)
Louisiana (7)
Maine (34)
Maryland (242)
Massachusetts (1136)
Michigan (87)
Minnesota (95)
Missouri (44)
Montana (19)
Nebraska (7)
Nevada (14)
New Hampshire (18)
New Jersey (617)
New Mexico (14)
New York (633)
North Carolina (302)
North Dakota (2)
Northern California (729)
Ohio (76)
Oklahoma (6)
Oregon (13)
Pennsylvania (377)
Puerto Rico (1)
Rhode Island (10)
South America (407)
South Carolina (7)
Southern California (610)
Tennessee (35)
Texas (291)
Utah (76)
Virginia (44)
Washington D.C. (14)
Washington State (160)
West Virginia (1)
Wisconsin (16)
192,059 Results for "zai lab".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Zai Lab Announces Acceptance of Supplemental New Drug Application for Repotrectinib for Patients with NTRK-Positive Solid Tumors
April 21, 2025
·
5 min read
Press Releases
Zai Lab Announces Participation in Investor Conferences in March 2025
March 3, 2025
·
1 min read
Press Releases
Zai Lab to Announce First Quarter 2025 Financial Results and Recent Corporate Updates on May 8, 2025
April 14, 2025
·
1 min read
Press Releases
Zai Lab to Present Data from Phase 1 Trial of DLL3-Targeted Antibody-Drug Conjugate (ADC) ZL-1310 at 2025 ASCO Annual Meeting
April 24, 2025
·
6 min read
Press Releases
Zai Lab to Present New Data from Internally Developed, Next-Generation Oncology Candidates at AACR 2025 Annual Meeting
March 27, 2025
·
5 min read
Press Releases
Zai Lab Announces Acceptance of Biologics License Application for TIVDAK for the Treatment of Patients with Recurrent or Metastatic Cervical Cancer
March 13, 2025
·
6 min read
Press Releases
Zai Lab Announces Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Updates
February 27, 2025
·
19 min read
Press Releases
Zai Lab Announces Acceptance of New Drug Application for KarXT for the Treatment of Schizophrenia
January 17, 2025
·
7 min read
Press Releases
Zai Lab Announces Participation in Investor Conference in January 2025
December 12, 2024
·
1 min read
Genetown
Zai Lab Announces Participation in May and June Investor Conferences
Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that members of the Company’s senior management team will participate in the following investor conferences in May and June 2024.
May 16, 2024
·
1 min read
1 of 19,206
Next
